Monograph No. 025 / Minerals
Minerals
Molybdenum: Benefits, Dosage, and Safety
Molybdenum is an essential trace mineral that forms the cofactor molybdopterin, which four enzymes need to metabolize sulfur-containing amino acids, purines, and certain drugs and toxins.
Molybdenum is an essential trace mineral that forms the cofactor molybdopterin, which four enzymes need to metabolize sulfur-containing amino acids, purines, and certain drugs and toxins.
What molybdenum is
Molybdenum is an essential trace element naturally present in many foods and available as a dietary supplement. It is a structural constituent of molybdopterin, a cofactor the body synthesizes that is required for four enzymes: sulfite oxidase, xanthine oxidase, aldehyde oxidase, and the mitochondrial amidoxime reducing component (mARC). Adults absorb roughly 40 percent to 100 percent of dietary molybdenum through a passive process, and the kidneys regulate body levels by excreting excess in urine. Molybdopterin-bound molybdenum is stored in the liver, kidney, adrenal glands, and bone.
What it does
- Serves as a structural part of molybdopterin, the cofactor needed by four enzymes
- Supports sulfite oxidase, which metabolizes sulfur-containing amino acids
- Supports xanthine oxidase and aldehyde oxidase in metabolizing purines, pyrimidines, and other heterocyclic compounds
- Contributes, via xanthine oxidase, aldehyde oxidase, and mARC, to the metabolism of certain drugs and toxins
How much molybdenum per day
These are population reference values from the NIH and the Dietary Reference Intakes. They are targets for healthy people, not personal prescriptions. The last column is the Tolerable Upper Intake Level, the most you should get from all sources combined.
| Life stage | Daily target | Type | Upper limit |
|---|---|---|---|
| Infants 0-6 months | 2 mcg/day | AI | not established |
| Infants 7-12 months | 3 mcg/day | AI | not established |
| Children 1-3 years | 17 mcg/day | RDA | 300 mcg/day |
| Children 4-8 years | 22 mcg/day | RDA | 600 mcg/day |
| Children 9-13 years | 34 mcg/day | RDA | 1,100 mcg/day |
| Adolescents 14-18 years | 43 mcg/day | RDA | 1,700 mcg/day |
| Adults 19+ years | 45 mcg/day | RDA | 2,000 mcg/day (2 mg/day) |
| Pregnancy 14-18 years | 50 mcg/day | RDA | 1,700 mcg/day |
| Pregnancy 19+ years | 50 mcg/day | RDA | 2,000 mcg/day (2 mg/day) |
| Lactation 14-18 years | 50 mcg/day | RDA | 1,700 mcg/day |
| Lactation 19+ years | 50 mcg/day | RDA | 2,000 mcg/day (2 mg/day) |
More is not better: staying near the target covers almost everyone, and routinely exceeding the upper limit can be harmful.
Deficiency and who is at risk
Dietary molybdenum deficiency has not been reported in otherwise healthy people. Deficiency effects are seen only in molybdenum cofactor deficiency, a rare inherited disorder in which molybdopterin cannot be synthesized, causing impaired sulfite metabolism, encephalopathy, and seizures, usually fatal within days of birth. A single 1981 case of acquired deficiency occurred in a patient on molybdenum-free total parenteral nutrition, who developed tachycardia, tachypnea, headache, night blindness, and coma that resolved with molybdenum administration.
Groups more likely to fall short
- People with molybdenum cofactor deficiency, a rare genetic metabolic disorder
- People on long-term total parenteral nutrition that lacks molybdenum
Who may need more
- No known groups of people are likely to have inadequate molybdenum intakes; most Americans consume adequate amounts from food
Food sources
Legumes are the richest sources. Examples per serving: black-eyed peas (boiled, 1/2 cup) 288 mcg; beef liver (pan fried, 3 oz) 104 mcg; lima beans (boiled, 1/2 cup) 104 mcg; plain low-fat yogurt (1 cup) 26 mcg; 2% milk (1 cup) 22 mcg; baked potato (1 medium) 16 mcg. Other notable sources are whole grains, nuts, leafy vegetables, and milk and cheese products.
Forms and absorption
Supplements provide molybdenum alone, combined with other minerals, or in multivitamin/mineral products, typically ranging from about 50 mcg to 500 mcg. Forms include molybdenum chloride, sodium molybdate, molybdenum glycinate, and molybdenum amino acid chelate. No studies have compared the relative bioavailability of these different forms.
Safety, excess and interactions
For healthy people, dietary molybdenum is considered safe because excess is rapidly excreted by the kidneys. Adverse effects are unlikely below the Tolerable Upper Intake Level, which is 2,000 mcg (2 mg) per day for adults 19 and older. Very high intakes (10 to 15 mg/day in a high-soil-molybdenum region) have been associated with joint aches, gout-like symptoms, and elevated blood uric acid. Supplement products typically supply 50 to 500 mcg, well within the UL. Anyone considering supplements should talk with a health care provider.
Too much
Acute molybdenum toxicity is rare and mainly linked to industrial mining and metalworking exposure. In healthy people a molybdenum-rich diet usually poses no risk because the mineral is rapidly excreted in urine. In one report from an area of Armenia with very high soil molybdenum, intakes of 10 to 15 mg/day were associated with achy joints, gout-like symptoms, and abnormally high blood uric acid levels. The Tolerable Upper Intake Levels were set based on impaired reproduction and fetal development observed in rats and mice, since human data were absent.
Interactions to know
- According to the NIH Office of Dietary Supplements, molybdenum has no known, clinically relevant interactions with medications
How status is measured
Not routinely measured. Because molybdenum deficiency is rare, status is not assessed in clinical settings and there is no established status biomarker. For reference, one small study reported serum molybdenum ranging from 0.28 ng/mL to 1.17 ng/mL (average 0.58 ng/mL); urinary molybdenum averages about 69 ng/mL but does not reflect molybdenum status.
What the evidence supports
We grade the strength of evidence behind each common reason people take molybdenum, mirroring how the NIH describes it.
Well-established role in normal human physiology per the NASEM Dietary Reference Intakes and ODS.
ODS states deficiency has not been reported except in the rare genetic molybdenum cofactor deficiency and one parenteral-nutrition case; no known groups are at risk of inadequacy.
ODS states molybdenum is not a standard treatment for any disease or disorder; no disease claims are supported.
Based on a single observational report from a high-soil-molybdenum region of Armenia at 10 to 15 mg/day; human toxicity data are sparse and ULs rest on animal studies.
Sources
- S1.gov verifiedNIH Office of Dietary Supplements (ODS)Molybdenum - Health Professional Fact Sheetods.od.nih.gov/factsheets/Molybdenum-HealthProfessio
- S2.gov verifiedNIH Office of Dietary Supplements (ODS)Molybdenum - Consumer Fact Sheetods.od.nih.gov/factsheets/Molybdenum-Consumer/
- S3.gov verifiedInstitute of Medicine (NASEM), Food and Nutrition BoardDietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zincnap.nationalacademies.org/catalog/10026
Every figure on this page is quoted from the sources above. Science changes; we re-check and re-date pages as authorities update their guidance.